DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

References

Bardia A, Diamond JR, Vahdat LT. et al.
Efficacy of sacituzumab govitecan (anti-Trop-2-SN-38 antibody-drug conjugate) for treatment-refractory hormone-receptor positive (HR+)/HER2– metastatic breast cancer (mBC).

J Clin Oncol 2018;
36 (Suppl.) Abstr.. 1004

Download Bibliographical Data

Search in:
Access: